IPCALABPharmaceuticals
Ipca Laboratories Ltd — Balance Sheet
₹1601.20
+1.02%
Ipca Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Ordinary Shares Number | 25.37 Cr | 25.37 Cr | 25.37 Cr | 25.37 Cr |
| Share Issued | 25.37 Cr | 25.37 Cr | 25.37 Cr | 25.37 Cr |
| Net Debt | 1.13K Cr | 1.18K Cr | 199.68 Cr | 516.05 Cr |
| Total Debt | 1.36K Cr | 1.44K Cr | 1.48K Cr | 807.22 Cr |
| Tangible Book Value | 6.75K Cr | 6.10K Cr | 5.64K Cr | 5.26K Cr |
| Other Short Term Investments | 937.88 Cr | 643.53 Cr | 921.22 Cr | 1.08K Cr |
| Cash And Cash Equivalents | 167.17 Cr | 208.91 Cr | 1.26K Cr | 275.19 Cr |
| Cash Equivalents | 38.83 Cr | 70.12 Cr | 1.17K Cr | 203.00 Cr |
| Cash Financial | 128.34 Cr | 138.79 Cr | 91.68 Cr | 72.19 Cr |
| Long Term Debt | 543.24 Cr | 580.41 Cr | 651.78 Cr | 395.18 Cr |
| Invested Capital | 8.25K Cr | 7.72K Cr | 7.30K Cr | 6.26K Cr |
| Working Capital | 3.88K Cr | 3.18K Cr | 3.38K Cr | 2.99K Cr |
| Net Tangible Assets | 6.75K Cr | 6.10K Cr | 5.64K Cr | 5.26K Cr |
| Capital Lease Obligations | 61.04 Cr | 50.86 Cr | 23.74 Cr | 15.98 Cr |
| Common Stock Equity | 6.95K Cr | 6.33K Cr | 5.84K Cr | 5.46K Cr |
| Total Capitalization | 7.49K Cr | 6.91K Cr | 6.49K Cr | 5.86K Cr |
| Total Equity Gross Minority Interest | 8.39K Cr | 7.73K Cr | 5.92K Cr | 5.54K Cr |
| Minority Interest | 1.44K Cr | 1.39K Cr | 73.30 Cr | 76.92 Cr |
| Stockholders Equity | 6.95K Cr | 6.33K Cr | 5.84K Cr | 5.46K Cr |
| Other Equity Interest | -24.43 Cr | -25.52 Cr | -27.13 Cr | -27.13 Cr |
| Retained Earnings | 5.53K Cr | 4.90K Cr | 4.40K Cr | 4.04K Cr |
| Additional Paid In Capital | 96.78 Cr | 96.78 Cr | 96.78 Cr | 96.78 Cr |
| Capital Stock | 25.37 Cr | 25.37 Cr | 25.37 Cr | 25.37 Cr |
| Common Stock | 25.37 Cr | 25.37 Cr | 25.37 Cr | 25.37 Cr |
| Total Liabilities Net Minority Interest | 3.37K Cr | 3.37K Cr | 2.71K Cr | 2.08K Cr |
| Total Non Current Liabilities Net Minority Interest | 986.06 Cr | 1.02K Cr | 905.29 Cr | 616.92 Cr |
| Other Non Current Liabilities | 0.64 Cr | 0.99 Cr | 2.47K Cr | 2.59 Cr |
| Non Current Accrued Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Tradeand Other Payables Non Current | 0.64 Cr | 0.87 Cr | — | — |
| Non Current Deferred Revenue | 0.00 | 0.12 Cr | 0.28 Cr | 0.54 Cr |
| Non Current Deferred Taxes Liabilities | 294.97 Cr | 310.47 Cr | 189.16 Cr | 164.38 Cr |
| Long Term Debt And Capital Lease Obligation | 594.14 Cr | 620.34 Cr | 668.86 Cr | 406.68 Cr |
| Long Term Capital Lease Obligation | 50.90 Cr | 39.93 Cr | 17.08 Cr | 11.50 Cr |
| Long Term Provisions | 96.31 Cr | 86.84 Cr | 46.99 Cr | 42.73 Cr |
| Current Liabilities | 2.39K Cr | 2.36K Cr | 1.81K Cr | 1.47K Cr |
| Other Current Liabilities | 86.78 Cr | 122.23 Cr | 69.02 Cr | 85.98 Cr |
| Current Deferred Taxes Liabilities | 48.25 Cr | 43.14 Cr | 22.76 Cr | 18.33 Cr |
| Current Debt And Capital Lease Obligation | 768.60 Cr | 818.02 Cr | 812.41 Cr | 400.54 Cr |
| Current Capital Lease Obligation | 10.14 Cr | 10.93 Cr | 6.66 Cr | 4.48 Cr |
| Current Debt | 758.46 Cr | 807.09 Cr | 805.75 Cr | 396.06 Cr |
| Current Provisions | 269.17 Cr | 244.56 Cr | 108.03 Cr | 198.58 Cr |
| Payables | 1.26K Cr | 1.20K Cr | 805.31 Cr | 741.57 Cr |
| Other Payable | 353.59 Cr | 336.70 Cr | 244.82 Cr | 130.78 Cr |
| Dividends Payable | 2.58 Cr | 2.80 Cr | 1.40 Cr | 1.29 Cr |
| Total Tax Payable | 60.33 Cr | 88.22 Cr | 34.03 Cr | 51.80 Cr |
| Accounts Payable | 846.17 Cr | 776.08 Cr | 525.06 Cr | 557.70 Cr |
| Total Assets | 11.76K Cr | 11.10K Cr | 8.63K Cr | 7.62K Cr |
| Total Non Current Assets | 5.49K Cr | 5.56K Cr | 3.44K Cr | 3.17K Cr |
| Other Non Current Assets | 24.83 Cr | 21.49 Cr | 0.31 Cr | 1.51 Cr |
| Non Current Prepaid Assets | 94.58 Cr | 196.08 Cr | 78.18 Cr | 59.64 Cr |
| Non Current Deferred Taxes Assets | 16.92 Cr | 4.23 Cr | 3.57 Cr | 2.02 Cr |
| Investmentin Financial Assets | 41.05 Cr | 26.56 Cr | 25.41 Cr | 25.19 Cr |
| Available For Sale Securities | 40.99 Cr | 26.50 Cr | 25.37 Cr | 25.15 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 0.06 Cr | 0.06 Cr | 0.04 Cr | 0.04 Cr |
| Long Term Equity Investment | 191.00 Cr | 284.99 Cr | 277.25 Cr | 244.69 Cr |
| Investmentsin Joint Venturesat Cost | 214.76 Cr | 176.45 Cr | 17.44 Cr | 7.62 Cr |
| Investmentsin Associatesat Cost | -23.76 Cr | 108.54 Cr | 130.00 Cr | 237.07 Cr |
| Goodwill And Other Intangible Assets | 203.24 Cr | 233.18 Cr | 197.23 Cr | 206.03 Cr |
| Other Intangible Assets | 112.66 Cr | 142.60 Cr | 159.09 Cr | 167.19 Cr |
| Goodwill | 90.58 Cr | 90.58 Cr | 38.14 Cr | 38.84 Cr |
| Net PPE | 4.76K Cr | 4.70K Cr | 2.73K Cr | 2.54K Cr |
| Accumulated Depreciation | -2.57K Cr | -2.25K Cr | -1.43K Cr | -1.19K Cr |
| Gross PPE | 7.34K Cr | 6.95K Cr | 4.16K Cr | 3.73K Cr |
| Construction In Progress | 693.71 Cr | 356.53 Cr | 159.22 Cr | 333.51 Cr |
| Other Properties | 218.95 Cr | 216.54 Cr | 203.16 Cr | 177.78 Cr |
| Machinery Furniture Equipment | 4.67K Cr | 4.37K Cr | 2.77K Cr | 2.29K Cr |
| Buildings And Improvements | 1.44K Cr | 1.36K Cr | 818.25 Cr | 714.01 Cr |
| Land And Improvements | 311.55 Cr | 645.84 Cr | 214.48 Cr | 215.66 Cr |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets | 6.27K Cr | 5.54K Cr | 5.19K Cr | 4.46K Cr |
| Other Current Assets | 7.96 Cr | 9.92 Cr | 5.74 Cr | 3.68 Cr |
| Assets Held For Sale Current | 301.50 Cr | 3.35 Cr | 0.00 | 10.46 Cr |
| Restricted Cash | 2.57 Cr | 2.80 Cr | 8.49 Cr | 12.29 Cr |
| Prepaid Assets | 105.24 Cr | 277.95 Cr | 66.49 Cr | 64.27 Cr |
| Inventory | 2.56K Cr | 2.47K Cr | 1.74K Cr | 1.86K Cr |
| Other Inventories | 89.63 Cr | 83.65 Cr | 58.32 Cr | 49.18 Cr |
| Finished Goods | 1.08K Cr | 1.01K Cr | 656.35 Cr | 726.03 Cr |
| Work In Process | 400.06 Cr | 417.00 Cr | 326.93 Cr | 357.92 Cr |
| Raw Materials | 995.14 Cr | 957.89 Cr | 701.77 Cr | 724.84 Cr |
| Other Receivables | 107.45 Cr | 103.04 Cr | 97.62 Cr | 145.68 Cr |
| Taxes Receivable | 204.53 Cr | 131.58 Cr | 99.47 Cr | 93.36 Cr |
| Accounts Receivable | 1.87K Cr | 1.69K Cr | 989.02 Cr | 910.78 Cr |
| Allowance For Doubtful Accounts Receivable | -6.44 Cr | -3.83 Cr | -0.68 Cr | -1.26 Cr |
| Gross Accounts Receivable | 1.88K Cr | 1.69K Cr | 989.70 Cr | 912.04 Cr |
| Cash Cash Equivalents And Short Term Investments | 1.11K Cr | 852.44 Cr | 2.18K Cr | 1.36K Cr |
| Investments In Other Ventures Under Equity Method | — | 157.02 Cr | 129.81 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | 0.00 | 0.00 |
| Pensionand Other Post Retirement Benefit Plans Current | — | — | 78.17 Cr | 67.93 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ipca Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.